Category Archives: Research

Representative Perlmutter of Colorado Co-Sponsors HR 1187 for Functional Gastrointestinal and Motility Disorders

According to IFFGD and the official Congressional legislative database Congress.gov, Representative Ed Perlmutter (D-CO-7) signed on in early July 2018 as a co-sponsor of the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017. Representative Perlmutter is serving his sixth term as a member of the House of Representatives. He represents Colorado’s 7th district …

Continue reading

Representative Connolly of Virginia Co-Sponsors HR 1187 for Functional Gastrointestinal and Motility Disorders

According to IFFGD and the official Congressional legislative database Congress.gov,  Representative Gerald (Gerry) Connolly (D-VA-11) signed on in early June 2018 as a co-sponsor of the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017. Representative Connolly is serving his fifth term as a member of the House of Representatives. He represents Virginia’s 11th …

Continue reading

Online Study: Cognitive Mediators of Bowel Discomfort Validation Study, Swinburne University, Australia, June 2018

The following study currently seeking men and women at least 18 years old in any country with chronic gastrointestinal conditions is a followup to an online study posted here on August 12, 2017.  The 2017 study is now closed to new volunteers. The current study has received institutional ethical approval. All information available to IBS …

Continue reading

Representative Price of North Carolina Co-Sponsors HR 1187 for Functional Gastrointestinal and Motility Disorders

According to IFFGD and the official Congressional legislative database Congress.gov,  Representative David Price (D-NC-4) signed on in late May 2018 as a co-sponsor of the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017. Representative Price is currently serving his sixteenth non-consecutive term in Congress representing the 4th District of North Carolina, which currently …

Continue reading

DNA Variants on Chromosome 9 Appear To Be Associated With Irritable Bowel Syndrome (IBS) in Some Women

In April 2018, the journal Gastroenterology published an article that an international collaboration of researchers headed by the Karolinska Institutet in Sweden, has identified several DNA variants on Chromosome 9 that may be associated with higher risk of IBS in women, particularly IBS with constipation. This possible correlation was not found in men. The identified …

Continue reading

Representatives Carson, Payne, Lofgren and Faso Co-Sponsor HR 1187 for Functional Gastrointestinal and Motility Disorders

According to IFFGD and the official Congressional legislative database Congress.gov, four members of the U.S. House of Representatives signed on in April and thus far in the first half of May 2018 as co-sponsors of the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017. They are Representative Andre Carson (D-IN-7), Representative Donald Payne, …

Continue reading

10 Years and 11 IBS Awareness Months: Progress for the IBS Community Continues in 2018

by Nina Pan, IBS Impact founder and primary blogger for IBS Impact. Five years ago, on April 24, 2013, I wrote a post for IBS Awareness Month that began with some reflections on my personal experiences with IBS, as well as my motivations for IBS Impact. At that time, I had been living with IBS for …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2018

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of diabetes, chronic …

Continue reading

IBS Network Conference and Exhibition for People with IBS and Professionals To Be Held April 14, 2018

Some of our readers in the vicinity of Sheffield in the United Kingdom may be interested in a one-day conference entitled, “Exploring the Self Management of IBS and What That Really Means to You” being offered by the IBS Network, the U.K’s national charity for irritable bowel syndrome,  at the Owen Building, Sheffield Hallam University …

Continue reading

Alosetron Risk Evaluation and Mitigation Strategies Paid Survey for Women Using Alosetron (Lotronex) Opens January 3, 2018

IBS Impact has received this notice directly from Alosetron Risk Evaluation and Mitigation Strategies Program on behalf of the U.S. FDA, and is posting at the program’s request.  This is paid survey for women who have taken alosetron (Lotronex) for IBS-D anytime in the last 12 months. The exact text provided to IBS Impact follows …

Continue reading